NCT02143323View on ClinicalTrials.gov

A Clinical Study to Explore Biomarkers for Drug-induced Liver Injury (DILI)

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy
Interventions
DRUG

Augmentin tablet

Trial Locations (2)

Unknown

Jieon Lee, Seoul

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02143323 - A Clinical Study to Explore Biomarkers for Drug-induced Liver Injury (DILI) | Biotech Hunter | Biotech Hunter